Scarica l'app Stockscreener
131.52
0.81%
-1.07
Dopo l'orario di chiusura:
131.95
0.43
+0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Biogen Inc Borsa (BIIB) Ultime notizie
Is Biogen Inc. a good long term investmentFree Stock Market Knowledge Sharing - PrintWeekIndia
Biogen is the latest entrant in NC’s corporate investment surge - Carolina Journal
KalVista, Biogen, Ionis get EU positive opinions for key drugs (KALV:NASDAQ) - Seeking Alpha
Biogen Inc. Announces Positive Opinion from EMA for ZURZUVAE® as First Marketing Authorization for Postpartum Depression Treatment in the EU - Quiver Quantitative
Biogen Inc. - Via Ritzau
Zacks Research Has Negative Outlook for Biogen Q2 Earnings - MarketBeat
Truist Financial Begins Coverage on Biogen (NASDAQ:BIIB) - MarketBeat
Genentech Seeks Win After $122M Biogen Royalties Mistrial - Law360
Biogen’s Felzartamab Trial: A Potential Game-Changer for Kidney Transplant Recipients - TipRanks
Biogen, Zydus Settle Patent Suit Over Copies of MS Drug Vumerity - Bloomberg Law News
Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy - TipRanks
Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $21.55 Million Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Victory Capital Management Inc. Purchases 5,723 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. Stock Analysis and ForecastExceptional gains - Autocar Professional
Biogen to invest $2 billion in RTP, open new factory in 2025 - WRAL.com
(BIIB) On The My Stocks Page - news.stocktradersdaily.com
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN
Rep. Robert Bresnahan, Jr. Buys Biogen Inc. (NASDAQ:BIIB) Shares - MarketBeat
How the Recombinant Dna Technology Market Will Evolve by 2032 - openPR.com
KLP Kapitalforvaltning AS Purchases 63,700 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Envestnet Asset Management Inc. Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Will Major North Carolina Expansion Change Biogen's (BIIB) Narrative? - simplywall.st
What drives Biogen Inc. stock pricePowerful growth strategies - jammulinksnews.com
Beacon Investment Advisory Services Inc. Sells 3,529 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division - Benzinga
Biogen, one of the largest employers in RTP, plans $2B investment in the Triangle - Axios
How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings? - The Globe and Mail
Allianz Asset Management GmbH Increases Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Los Angeles Capital Management LLC Takes $5.93 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Spinal Muscular Atrophy Treatment Market Growth Accelerated - openPR.com
Biogen: Hold Rating Amid Stagnant Growth and Uncertain Prospects - TipRanks
Biogen to invest additional $2B in North Carolina’s Research Triangle Park - MSN
Biogen to invest further $2bn in North Carolina’s Research Triangle Park - Yahoo Finance
Iovance Biotherapeutics shares rise 2.41% premarket after Biogen's $2 billion investment in North Carolina manufacturing. - AInvest
AustralianSuper Pty Ltd Buys New Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
What analysts say about Biogen Inc. stockFree Predictions - jammulinksnews.com
Biogen investing $2B to expand operations in RTP - ABC11
Biogen's Alzheimer's Innovation Pipeline: Lecanemab and BIIB080 as Catalysts for Long-Term Growth - AInvest
Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi - yahoo.co
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025 - Biogen
Biogen Breakthrough: 48-Month LEQEMBI Results Plus Game-Changing Subcutaneous Alzheimer's Treatment Option - Stock Titan
Edgestream Partners L.P. Sells 3,285 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen to invest $2 billion in RTP facility - CBS 17
Biogen Inc. Invests $2B In North Carolina Expansion - Business Facilities
Biogen Inc. Announces $2 Billion Expansion in North Carolina's Research Triangle Park Amid U.S. Manufacturing Push - Hoodline
Friedreich's Ataxia Market Is Expanding Due To Advancing - openPR.com
Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance
Biogen Bets Big On $2 Billion Expansion To Boost US Drug ManufacturingBiogen (NASDAQ:BIIB) - Benzinga
Biogen invests $2B in U.S. manufacturing — but not in Massachusetts - The Business Journals
Biogen to invest $2 billion in Research Triangle Park facilities - CBS 17
Biogen’s Pediatric RRMS Study Completion: Market Implications and Insights - TipRanks
Biogen Invests $20 Billion in North Carolina to Counter 200% Tariff Threat - AInvest
Biogen to invest further $2 billion in North Carolina facilities - The Pharma Letter
Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm - Reuters
0.48%
2.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):